These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22752239)

  • 21. Evidence for reduced tonic levels of GABA in the hippocampus of an animal model of ADHD, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2013 Dec; 1541():52-60. PubMed ID: 24161405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder.
    Narr KL; Woods RP; Lin J; Kim J; Phillips OR; Del'Homme M; Caplan R; Toga AW; McCracken JT; Levitt JG
    J Am Acad Child Adolesc Psychiatry; 2009 Oct; 48(10):1014-1022. PubMed ID: 19730275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperactivity and impaired attention in Gamma aminobutyric acid transporter subtype 1 gene knockout mice.
    Chen L; Yang X; Zhou X; Wang C; Gong X; Chen B; Chen Y
    Acta Neuropsychiatr; 2015 Dec; 27(6):368-74. PubMed ID: 26072958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients.
    Solleveld MM; Schrantee A; Puts NAJ; Reneman L; Lucassen PJ
    Neuroimage Clin; 2017; 15():812-818. PubMed ID: 28725548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder.
    Shaw P; Lerch J; Greenstein D; Sharp W; Clasen L; Evans A; Giedd J; Castellanos FX; Rapoport J
    Arch Gen Psychiatry; 2006 May; 63(5):540-9. PubMed ID: 16651511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional brain correlates of motor response inhibition in children with developmental coordination disorder and attention deficit/hyperactivity disorder.
    Thornton S; Bray S; Langevin LM; Dewey D
    Hum Mov Sci; 2018 Jun; 59():134-142. PubMed ID: 29655169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study.
    Carrey N; MacMaster FP; Fogel J; Sparkes S; Waschbusch D; Sullivan S; Schmidt M
    Clin Neuropharmacol; 2003; 26(4):218-21. PubMed ID: 12897644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GAD1 gene polymorphisms are associated with hyperactivity in Attention-Deficit/Hyperactivity Disorder.
    Bruxel EM; Akutagava-Martins GC; Salatino-Oliveira A; Genro JP; Zeni CP; Polanczyk GV; Chazan R; Schmitz M; Rohde LA; Hutz MH
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1099-1104. PubMed ID: 27530595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABA and primary motor cortex inhibition in young and older adults: a multimodal reliability study.
    Mooney RA; Cirillo J; Byblow WD
    J Neurophysiol; 2017 Jul; 118(1):425-433. PubMed ID: 28424294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of cortical and subcortical abnormalities in drug-naive boys with attention-deficit/hyperactivity disorder.
    Lu L; Zhang L; Tang S; Bu X; Chen Y; Hu X; Hu X; Li H; Guo L; Sweeney JA; Gong Q; Huang X
    J Affect Disord; 2019 May; 250():397-403. PubMed ID: 30877863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
    Karic S; DesRosiers M; Mizrahi B; Zevallos J; Rodriguez P; Barengo NC
    Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related parietal GABA alterations in children with autism spectrum disorder.
    DeMayo MM; Harris AD; Song YJC; Pokorski I; Thapa R; Patel S; Ambarchi Z; Thomas EE; Hickie IB; Guastella AJ
    Autism Res; 2021 May; 14(5):859-872. PubMed ID: 33634588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain gray matter deficits at 33-year follow-up in adults with attention-deficit/hyperactivity disorder established in childhood.
    Proal E; Reiss PT; Klein RG; Mannuzza S; Gotimer K; Ramos-Olazagasti MA; Lerch JP; He Y; Zijdenbos A; Kelly C; Milham MP; Castellanos FX
    Arch Gen Psychiatry; 2011 Nov; 68(11):1122-34. PubMed ID: 22065528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention-deficit/hyperactivity disorder.
    Yeo RA; Hill DE; Campbell RA; Vigil J; Petropoulos H; Hart B; Zamora L; Brooks WM
    J Am Acad Child Adolesc Psychiatry; 2003 Mar; 42(3):303-10. PubMed ID: 12595783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential pathomechanisms of ADHD based on neurometabolite changes.
    Husarova V; Ondrejka I; Tonhajzerova I
    Neuro Endocrinol Lett; 2010; 31(4):438-45. PubMed ID: 20802444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Magnetic Resonance Spectroscopy Study of Superior Visual Search Abilities in Children with Autism Spectrum Disorder.
    Edmondson DA; Xia P; McNally Keehn R; Dydak U; Keehn B
    Autism Res; 2020 Apr; 13(4):550-562. PubMed ID: 31909886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain magnetic resonance spectroscopy in Sydenham's chorea and ADHD.
    Margari L; Ventura P; Portoghese C; Presicci A; Buttiglione M; Di Cuonzo F
    Pediatr Neurol; 2006 Jun; 34(6):467-73. PubMed ID: 16765826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel pharmacological targets for GABAergic dysfunction in ADHD.
    Ferranti AS; Luessen DJ; Niswender CM
    Neuropharmacology; 2024 May; 249():109897. PubMed ID: 38462041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.